Single Nucleotide Polymorphisms on Toll-like Receptor-4 and the Risk of Developing Skin Cancer

Exposure to solar ultraviolet (UV) radiation is an established risk factor for skin cancer. Toll-like receptor-4 (TLR4)-mediated immune dysregulation has emerged as a key mechanism for the detrimental effects of acute and chronic UV exposure and skin cancer in mice. Single nucleotide polymorphisms (SNPs) on the <i>TLR4</i> gene have been reported to increase or decrease susceptibility to various cancers in other organs. There is limited information on <i>TLR4</i> SNPs and susceptibility to human keratinocyte carcinomas. The study's objective is to test the association between <i>TLR4</i> SNPs and the risk of developing keratinocyte carcinomas. Skin cancer patients and controls at the University of Alabama at Birmingham completed a cross-sectional survey on personal and family history of skin cancer as well as on sunscreen use and tanning proneness. Peripheral blood samples were obtained from participants, and DNA was extracted to genotype the <i>TLR4</i> SNPs. Descriptive analytics were used to describe the cohort. Multivariable logistic regression models were used to assess the association between <i>TLR4</i> SNPs and skin cancer risk. The sample consisted of a cohort of 93 skin cancer patients over the age of 50 and 94 controls; 33.3% of cases and 44.7% of controls were females; 12.9% of cases and 17% of controls had a <i>TLR4</i> SNP. The most common SNP was D299G/T399I in 9.7% of skin cancer patients and 13.8% of controls. We did not find a statistically significant association between the D299G/T399I SNP and skin cancer (odds ratio (OR) = 0.34, 95% CI: 0.11, 1.07, <i>p</i> = 0.065) adjusting for age, sex, eye color, actinic keratosis, sunscreen use and reapplication, and family history of skin cancer. Based on our findings from our limited cohort of participants, we found some protective effect for the <i>TLR4</i> SNP for skin cancer, which was not statistically significant. Validation of these findings in a larger cohort is warranted.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2024-11-27
DOI
https://doi.org/10.3390/ijms252312728
Primary Topic
Immune Response and Inflammation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Single Nucleotide Polymorphisms on Toll-like Receptor-4 and the Risk of Developing Skin Cancer

Noha Sharafeldin, Craig A. Elmets, Nabiha Yusuf, Tom Callens et al.
International Journal of Molecular Sciences
Immune Response and Inflammation
article

Single Nucleotide Polymorphisms on Toll-like Receptor-4 and the Risk of Developing Skin Cancer

Noha Sharafeldin, Craig A. Elmets, Nabiha Yusuf, Tom Callens, Mohammad Saleem, Ludwine M. Messiaen
article en

Abstract

Exposure to solar ultraviolet (UV) radiation is an established risk factor for skin cancer. Toll-like receptor-4 (TLR4)-mediated immune dysregulation has emerged as a key mechanism for the detrimental effects of acute and chronic UV exposure and skin cancer in mice. Single nucleotide polymorphisms (SNPs) on the <i>TLR4</i> gene have been reported to increase or decrease susceptibility to various cancers in other organs. There is limited information on <i>TLR4</i> SNPs and susceptibility to human keratinocyte carcinomas. The study's objective is to test the association between <i>TLR4</i> SNPs and the risk of developing keratinocyte carcinomas. Skin cancer patients and controls at the University of Alabama at Birmingham completed a cross-sectional survey on personal and family history of skin cancer as well as on sunscreen use and tanning proneness. Peripheral blood samples were obtained from participants, and DNA was extracted to genotype the <i>TLR4</i> SNPs. Descriptive analytics were used to describe the cohort. Multivariable logistic regression models were used to assess the association between <i>TLR4</i> SNPs and skin cancer risk. The sample consisted of a cohort of 93 skin cancer patients over the age of 50 and 94 controls; 33.3% of cases and 44.7% of controls were females; 12.9% of cases and 17% of controls had a <i>TLR4</i> SNP. The most common SNP was D299G/T399I in 9.7% of skin cancer patients and 13.8% of controls. We did not find a statistically significant association between the D299G/T399I SNP and skin cancer (odds ratio (OR) = 0.34, 95% CI: 0.11, 1.07, <i>p</i> = 0.065) adjusting for age, sex, eye color, actinic keratosis, sunscreen use and reapplication, and family history of skin cancer. Based on our findings from our limited cohort of participants, we found some protective effect for the <i>TLR4</i> SNP for skin cancer, which was not statistically significant. Validation of these findings in a larger cohort is warranted.

International Journal of Molecular SciencesVol. 25(23)
University of Alabama at Birmingham (US)
Good health and well-being
Openalex Percentile: Top 72%
Immune Response and Inflammation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.